Frontiers is the 3rd most-cited research publisher and reports groundbreaking discoveries by the world's top experts. Frontiers, Experimental Therapeutics is now accepting submissions that highlight the roles of enzymes in neurological injury or disease. Authors are also encouraged to submit relevant work describing enzymes associated with infectious agents, e.g. SARS-CoV-2, as applicable to neurological symptoms and / or damage.
Visit Frontiers to learn more
To learn how we can assist with your needs within science and medicine, visit Aries Biotech at https://www.ariesbiotechnologies.org.